Ataxin 2 Antikörper (Middle Region)
Kurzübersicht für Ataxin 2 Antikörper (Middle Region) (ABIN927703)
Target
Alle Ataxin 2 (ATXN2) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- Middle Region
-
Kreuzreaktivität
- Maus, Rind (Kuh), Hund
-
Aufreinigung
- Purified
-
Immunogen
- ATXN2 antibody was raised in rabbit using the middle region of ATXN2 as the immunogen
-
-
-
-
Applikationshinweise
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
ATXN2 Blocking Peptide, (ABIN939080), is also available for use as a blocking control in assays to test for specificity of this ATXN2 antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Konzentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- Ataxin 2 (ATXN2)
-
Andere Bezeichnung
- ATXN2
-
Hintergrund
- The autosomal dominant cerebellar ataxias (ADCA) are a heterogeneous group of neurodegenerative disorders characterized by progressive degeneration of the cerebellum, brain stem and spinal cord. Clinically, ADCA has been divided into three groups: ADCA ty. Synonyms: Polyclonal ATXN2 antibody, Anti-ATXN2 antibody, ataxin 2 antibody, ATX2 antibody, FLJ46772 antibody, SCA2 antibody, TNRC13 antibody.
-
Pathways
- Ribonucleoprotein Complex Subunit Organization
Target
-